New hope for hodgkin lymphoma patients unable to tolerate chemo

NCT ID NCT05977673

Recruiting now Disease control Sponsor: Fondazione Italiana Linfomi - ETS Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a drug called tislelizumab in people with newly diagnosed Hodgkin lymphoma who are not able to receive standard chemotherapy. The goal is to see if the drug can shrink or control the cancer. About 28 participants will take part in this phase 2 trial.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLASSICAL HODGKIN LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

classic Hodgkin lymphoma Hodgkins lymphoma lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HODGKIN LYMPHOMA

Contacts and locations

Locations

A.O. SS. Antonio e Biagio e Cesare Arrigo, S.C. Ematologia
RECRUITING

Alessandria, IT, Italy
Divisione di Oncologia e dei Tumori immuto-correlati, Centro Di Riferimento Oncologico Di Aviano
RECRUITING

Aviano, Italy
Ematologia, Fondazione IRCCS Istituto Nazionale Dei Tumori
RECRUITING

Milan, Italy
Istituto Ematologia -Dipartimento di Medicina Traslazionale e di Precisione, Azienda Ospealiero Universitaria Policlinico Umberto I
RECRUITING

Roma, Italy
Istituto di Ematologia L. e A. Seràgnoli, AOU Policlinico S. Orsola-Malpighi
RECRUITING

Bologna, Italy
Oncoematologia, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello
NOT_YET_RECRUITING

Palermo, Italy
Oncologia, IRCCS Istituto Nazionale Tumori Fondazione Pascale
RECRUITING

Naples, Italy
SC Ematologia, Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia
RECRUITING

Brescia, Italy
U.O di Oncologia Medica ed Ematologia, Humanitas Research Hospital
RECRUITING

Rozzano, Italy
Unità di Ematologia e TMO - Unità Linfomi, Ospedale San Raffaele
RECRUITING

Milan, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.